Detalles de la búsqueda
1.
PATIENT PRIORITIES FOR TREATMENT ATTRIBUTES IN ADJUNCTIVE DRUG THERAPY OF SEVERE HYPERCHOLESTEROLEMIA IN GERMANY: AN ANALYTIC HIERARCHY PROCESS.
Int J Technol Assess Health Care
; 34(3): 267-275, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29987994
2.
Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis.
BMC Neurol
; 14: 58, 2014 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-24666846
3.
Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin.
Int J Clin Pharmacol Ther
; 50(1): 24-32, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22192642
4.
Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: a systematic review.
Cost Eff Resour Alloc
; 9(1): 15, 2011 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-21978524
5.
Comparison of treatment costs in inadequately controlled type 2 diabetes in Germany based on the APOLLO trial with insulin glargine.
J Med Econ
; 12(2): 87-97, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19473110
6.
Resource utilisation and costs in patients with type 2 diabetes mellitus treated with insulin glargine or conventional basal insulin under real-world conditions in Germany: LIVE-SPP study.
J Med Econ
; 11(4): 695-712, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-19450076
7.
Statin-associated myopathy. Assessment of frequency based on data of all statutory health insurance funds in Germany.
Pharmacol Res Perspect
; 6(3): e00404, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29760929
8.
Treatment Preferences in Germany Differ Among Apheresis Patients with Severe Hypercholesterolemia.
Pharmacoeconomics
; 36(4): 477-493, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29388056
9.
Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
Atherosclerosis
; 268: 99-107, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29197254
10.
Prevalence of high-risk cardiovascular patients with therapy-resistant hypercholesterolemia.
Cardiovasc Endocrinol
; 6(2): 81-85, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28540139
11.
[Analysis of Secondary Data to Determine the Prevalence of Cardiovascular High Risk Patients with Hypercholesterolemia and Refractory Course of Treatment]. / Sekundärdatenanalyse zur Ermittlung der Prävalenz von kardiovaskulären Hochrisiko-Patienten mit Hypercholesterinämie und therapierefraktärem Behandlungsverlauf.
Dtsch Med Wochenschr
; 142(6): e34-e41, 2017 Mar.
Artículo
en Alemán
| MEDLINE | ID: mdl-28329898
12.
'Knowing what matters in diabetes: healthier below 7': results of the campaign's first 10 years (part 1): participants with known type 2 diabetes.
Cardiovasc Endocrinol
; 5(1): 14-20, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28392972
13.
Early discontinuation and related treatment costs after initiation of Basal insulin in type 2 diabetes patients: a German primary care database analysis.
J Diabetes Sci Technol
; 9(3): 644-50, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25573957
14.
Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis.
Prim Care Diabetes
; 9(5): 377-84, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25701545
15.
Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis.
Prim Care Diabetes
; 8(2): 127-31, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24183472
16.
Predictors of insulin initiation in metformin and sulfonylurea users in primary care practices: the role of kidney function.
J Diabetes Sci Technol
; 8(5): 1023-8, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24876433
17.
Relevance of indirect comparisons in the German early benefit assessment and in comparison to HTA processes in England, France and Scotland.
Health Econ Rev
; 4(1): 31, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26208931
18.
Resource consumption and costs of treatment in patients with type 1 diabetes under intensified conventional therapy under German real-life conditions.
J Diabetes Sci Technol
; 7(3): 736-42, 2013 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23759407
19.
Predictors for the initiation of a basal supported oral therapy (BOT) in type 2 diabetic patients under real-life conditions in Germany.
Prim Care Diabetes
; 6(4): 329-35, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22749713
20.
Amputation rate and risk factors in type 2 patients with diabetic foot syndrome under real-life conditions in Germany.
Prim Care Diabetes
; 6(3): 241-6, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22445058